Skip to main content

Day: January 13, 2026

ETC Announces Fiscal 2026 Third Quarter Results

SOUTHAMPTON, Pa., Jan. 13, 2026 (GLOBE NEWSWIRE) — Environmental Tectonics Corporation (OTCID: ETCC) (“ETC” or the “Company”) today reported its financial results for the thirteen week period ended November 28, 2025 (the “2026 fiscal third quarter”). Robert L. Laurent, Jr., ETC’s Chief Executive Officer and President stated, “Sales declined in the third fiscal quarter as we have been executing against several large contracts, which are in the final phase of completion. However, we are pleased with the 12% increase in ETC sales backlog at the end of 2026 fiscal third quarter to $69.7 million as compared to $62.3 million at the end of the 2026 second fiscal quarter. This increase was driven by $20.0 million in new contract awards in 2026 fiscal third quarter. The increased sales backlog and the large pipeline of opportunities positions...

Continue reading

ECD Automotive Design Introduces the Heritage Product Line

A Return to the Defender, Exactly as It Was Meant to BeKISSIMMEE, Fla., Jan. 13, 2026 (GLOBE NEWSWIRE) — ECD Automotive Design, the world’s largest Land Rover and Jaguar restoration company known for its bespoke Defenders, Range Rovers, Jaguar E-Types, Ford Mustangs, Toyota FJs, and the ECDXCTC INEOS Grenadier and Defender II, proudly announces the launch of its new Heritage Product Line, a deeply authentic offering created for purists who believe the soul of the Land Rover Defender is found in its simplicity, mechanical honesty, and unrivaled sense of purpose. Priced from $159,995, the Heritage line is available in both Defender 90 and Defender 110 configurations, the Heritage line is a celebration of where the Defender began, and why it still matters today. Images of ECD’s Heritage Line Video of ECD’s Heritage Line At the heart...

Continue reading

NextNRG Validates Scalable Healthcare Microgrid Platform Through Executed Long-Term PPAs

Executed Agreements Across Assisted Living and Rehabilitation Facilities Demonstrate a Repeatable Infrastructure Model for a Mission-Critical Healthcare Vertical MIAMI, FL, Jan. 13, 2026 (GLOBE NEWSWIRE) — NextNRG, Inc. (NASDAQ: NXXT), a pioneer in AI-driven energy innovation transforming how energy is produced, managed, and delivered, today highlighted that its previously announced healthcare microgrid power purchase agreements (PPAs) validate a scalable, vertical-focused infrastructure approach  for long-term deployment in mission-critical energy markets. Executed agreements across assisted living and rehabilitation facilities confirm the Company’s ability to deploy standardized, long-duration energy infrastructure in environments requiring continuous uptime, regulatory compliance, and predictable energy costs. Together, these...

Continue reading

Inotiv Leverages LifeNet Health Proprietary Platform to Advance New Approach Methodologies in Translational Drug Discovery

WEST LAFAYETTE, Ind., Jan. 13, 2026 (GLOBE NEWSWIRE) — Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, or “Inotiv”), a leading Contract Research Organization specializing in nonclinical and analytical drug discovery and development services and research models and related products and services, today announced a strategic initiative to leverage LifeNet Health’s proprietary TruVivo® within its Discovery and Translational Sciences business. LifeNet Health, a global leader in regenerative medicine, has developed the patented TruVivo® system, which uses primary human hepatocytes cultured with human-derived feeder cells to create physiologically relevant in vitro models. This technology provides a stronger foundation for predicting human responses to new therapies and addresses a critical challenge in drug development. “Translational science...

Continue reading

iPower Highlights Channel Partner Role at Zyla by Ant International Event During Consumer Electronics Show

RANCHO CUCAMONGA, Calif., Jan. 13, 2026 (GLOBE NEWSWIRE) — iPower Inc. (Nasdaq: IPW) (“iPower” or the “Company”) today announced its recent participation at a Event hosted by Zyla by Ant International (“Zyla”). The Company was introduced as a U.S. retail channel partner supporting Zyla’s clients, highlighting iPower’s expertise in expanding their online sales presence in the United States. iPower’s platform capabilities are designed to help brands and sellers scale across major U.S. online channels through a combination of marketplace experience, operational execution, and value-added enablement services. The Company believes its role as a channel partner can support international merchants seeking to accelerate U.S. e-commerce growth. Following the event, iPower has been approached by several supply-chain partners to explore potential...

Continue reading

Creative Medical Technology Holdings Reaches Major Clinical Inflection Point with Positive Interim Data from ADAPT Trial and CELZ-201 (Olastrocel) in the Treatment of Chronic Lower Back Pain

Data Show Strong Functional and Pain Improvements Supported by Excellent Safety Profile PHOENIX, Jan. 13, 2026 (GLOBE NEWSWIRE) — Creative Medical Technology Holdings, Inc. (NASDAQ: CELZ) (“Creative Medical” or the “Company”), a clinical-stage biotechnology company advancing regenerative medicine solutions, today announced positive interim 180-day follow-up data from its FDA-cleared ADAPT clinical trial evaluating CELZ-201 (Olastrocel), the Company’s proprietary perinatal tissue-derived cell therapy for chronic lower back pain associated with degenerative disc disease. The study produced statistically significant, clinically meaningful improvements in both functional disability (ODI%) and pain at primary trial end point, confirming durable human efficacy alongside an excellent safety profile. The announcement of this data follows...

Continue reading

Signing Day Sports Announces Pricing of $5.6 Million Public Offering

SCOTTSDALE, Arizona, Jan. 13, 2026 (GLOBE NEWSWIRE) — Signing Day Sports, Inc. (“Signing Day Sports” or the “Company”) (NYSE American: SGN), the developer of the Signing Day Sports app and platform to aid high school athletes in the recruitment process, today announced the pricing of its public offering of 9,483,500 shares of common stock, which are being offered together with warrants to purchase 14,225,250 shares of common stock, at a public offering price of $0.5905 per share and accompanying warrant. The warrants will be initially exercisable at a price of $0.7086 per share. The warrants may also be exercised on a zero cash exercise basis for a number of shares of common stock pursuant to the formula defined in the warrants subject to a floor price of $0.6760 per share and subject to a beneficial ownership limitation, and may...

Continue reading

Intuitive Machines Completes Acquisition of Lanteris Space Systems

The acquisition positions Intuitive Machines to be a vertically integrated next-generation space prime contractor for commercial, civil and national security space initiatives HOUSTON, Jan. 13, 2026 (GLOBE NEWSWIRE) — Intuitive Machines, Inc. (Nasdaq: LUNR) (“Intuitive Machines”) or the (“Company”), a leading space technology, infrastructure, and services company, has completed its acquisition of Lanteris Space Systems (“Lanteris”), formerly Maxar Space Systems, a proven spacecraft manufacturer with an exceptional record of delivering a highly reliable family of spacecraft for national security, civil, and commercial customers. The acquisition, first announced on November 4, 2025, was completed for $800 million before closing adjustments, consisting of $450 million in cash and $350 million in Intuitive Machines Class A common stock. “This...

Continue reading

Vericel Announces Preliminary 2025 Financial Results and Business Updates

Total Revenue Expected to be $276 Million  MACI Revenue Expected to be $239.5 Million Fourth Quarter Total Revenue and MACI Revenue Growth of 23% CAMBRIDGE, Mass., Jan. 13, 2026 (GLOBE NEWSWIRE) — Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced preliminary, unaudited financial results and other business updates for the fourth quarter and year ended December 31, 2025. Preliminary, Unaudited Full-Year 2025 Financial ResultsTotal net revenue expected to be approximately $276 million, with MACI® net revenue of $239.5 million and Burn Care net revenue of $36.5 million Gross margin expected to be 74% and adjusted EBITDA margin expected to be 26% GAAP Net Income profitability expected for the second consecutive year $200 million in cash and investments,...

Continue reading

Freight Technologies Bolsters Fleet Rocket With 19 New Integrated GPS Providers

Increase brings the total number of GPS network providers to 73 via the Company’s real-time freight geolocation module, Fr8Radar HOUSTON, Jan. 13, 2026 (GLOBE NEWSWIRE) — Freight Technologies, Inc. (Nasdaq: FRGT, “Fr8Tech” or the “Company”), a technology-driven logistics company leveraging artificial intelligence and offering a diversified portfolio of AI-enabled software solutions designed to address key inefficiencies in the supply chain, today announced the continued expansion of Fleet Rocket, its cloud-based Transportation Management System (TMS), driven by accelerating adoption of its Fr8Radar GPS integration network. Since October 2025, Fleet Rocket has added 19 new GPS providers, bringing the total number of integrated GPS networks to 73 across the U.S. and Mexico. The increase represents the strongest period of GPS integration...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.